Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)
Cancer Pathogenesis and Therapy · 2025-05 · 3 (3) · 183-196
DOI: 10.1016/j.cpt.2024.07.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2025-05. Verfasst von Runjie Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fudan University Zhongshan Hospital, Shanghai Municipal Health Commission, Shanghai Shenkang Hospital Development Center.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with increasing incidences worldwide. The overall 5-year survival rate remains low, underscoring the urgent need for effective therapies. Despite the promising efficacy of immunotherapy for various solid tumors, its benefits for pancreatic cancer have been disappointing. This is largely because of the complex and unique mechanisms of immune evasion inherent in PDAC. Emerging evidence has highlighted the pivotal role of tumor-associated macrophages (TAMs) in facilitating the immune escape of PDAC. TAMs significantly contribute to forming an immunosuppressive microenvironment, which hinders the effectiveness of immunotherapeutic approaches. They achieve this through multiple pathways, including the secretion of cytokines and the promotion or inhibition of multiple immune cells. In this review, we summarized the main pathways through which TAMs form an immunosuppressive microenvironment in PDAC. We also examined the current status and recent progress of immunotherapy strategies that specifically target macrophages. By understanding these mechanisms and exploring targeted therapies, we aimed to shed light on potential avenues for improving the treatment outcomes of this devastating disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi 030000, China.
- Department of Basic Medicine and Institute of Liver Diseases, Shanxi Medical University, Taiyuan, Shanxi 030000, China.
- Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Förderung
- Fudan University Zhongshan Hospital
- Shanghai Municipal Health Commission
- Shanghai Shenkang Hospital Development Center
- National Natural Science Foundation of China
- Beijing Xisike Clinical Oncology Research Foundation
- China Postdoctoral Science Foundation
- Major Science and Technology Projects in Yunnan Province
Zitieren
APA
Liu, R., Li, J., Liu, L., Wang, W., & Jia, J. (2025). Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Cancer Pathogenesis and Therapy, 3(3), 183-196. https://doi.org/10.1016/j.cpt.2024.07.004
Vancouver
Liu R, Li J, Liu L, Wang W, Jia J. Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Cancer Pathogenesis and Therapy. 2025;3(3):183-196. doi:10.1016/j.cpt.2024.07.004
BibTeX
@article{Liu2025,
author = {Liu, Runjie and Li, Jianang and Liu, Liang and Wang, Wenquan and Jia, Jinbin},
title = {Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)},
journal = {Cancer Pathogenesis and Therapy},
year = {2025},
volume = {3},
number = {3},
pages = {183--196},
doi = {10.1016/j.cpt.2024.07.004}
}
EUVIMED